Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $7.4650 (-4.96%) ($7.4650 - $7.4650) on Tue. May. 16, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.38% (three month average) | RSI | 80 | Latest Price | $7.4650(-4.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 0.5% a day on average for past five trading days. | Weekly Trend | IOVA advances 13.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) XBI(37%) ACES(31%) IBB(24%) BLOK(22%) IWC(20%) | Factors Impacting IOVA price | IOVA will decline at least -2.19% in a week (0% probabilities). XLP(-23%) XLU(-17%) UUP(-17%) SPLV(-16%) USO(-12%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.19% (StdDev 4.38%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.6(-1.78%) | 10 Day Moving Average | $7.28(2.54%) | 20 Day Moving Average | $6.54(14.14%) | To recent high | -5% | To recent low | 39.1% | Market Cap | $1.093b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |